INN caught up with Richard Carleton of the Canadian Securities Exchange to discuss the rush of interest in investing in psychedelics.
A Canadian securities executive believes psychedelics investment opportunities at their core relate most to the pharmaceutical industry.
The Investing News Network (INN) met up online with Richard Carleton, CEO of the Canadian Securities Exchange (CSE), to discuss the growth potential of psychedelics as an investment proposal and the role he expects his exchange to see.
He also told INN about his reaction the first time he heard about psychedelics investing.
While excitement about the psychedelics arena is starting to add up, Carleton was more measured and said the industry…